站内搜索
|
首页 > Products > Glycosylated Hemoglobin Hba1c Diagnostic Kits/ Quantitative Result with Ngsp Certificate
详细信息 Product Name: Glycosylated Hemoglobin Hba1c Diagnostic Kits/ Quantitative Result with Ngsp Certificate Model NO.: CG1017 Group: All Men Certification: CE, ISO13485 Type: Poct Reagent Classification: Biological Diagnostics Suitable Machine: Fia 8000/Fia8600 Trademark: GP Transport Package: Carton Specification: 25 test/box Origin: Jiangsu HS Code: 3002190090 Product Description Basic informationThe One Step Test for HbA1c (colloidal gold) is intended for use together with the FIA8000 Quantitative Immunoassay Analyzer (FIA8000). The product employs colloidal gold immunochromatogrphy to determine HbA1c in human whole blood specimens. Two monoclonal antibodies are employed to identify HbA1c specifically, resulting in apurplish red streak appears on the test line. The color intensity of the test line increases in proportion to the concentrations of HbA1c.Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of HbA1c is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.Products Code: CG 1017Detection Method: colloidal gold, aquantitative test for use with the FIA8000 Quantitative Immunoassay Analyzer. Detection Range: 2~14%Expected Range of Value: 3.8~5.8%Sample Type: whole blood in Heparin/Sodium Citrate/EDTA.Reaction Time: yields results in about 3minutes.Storage Temperature: 4-30°CSelf Time: 24 months. Use the test card within 1hour once the foil bag is opened.PackageA box package contains 25 tests:Foil bag, which contains one test card and one desiccant25Disposable pipet25Manual1SD card1Sample diluent25This test is used as an aid for monitoring glycemic control in diabetics. In addition, it can identify people at risk of developing the disease and ongoing monitoring.Any questions or interests, please contact us.Website:http://www.bio-gp.com.cn/EN/Index.aspxAdd:No.9 Bofu Road,Luhe Distric, Nanjing,211505,ChinaPostal:211505Company ProfileGetein Biotech Inc. (stock code: 603387), established in 2002, is afully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes abroad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and avariety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.
|